Abstract
. Objective: COX inhibitors and b-adrenergic blockers were recently shown to reduce cancer progression in animal models through various mechanisms. These include the prevention of immune suppression during the critical perioperative period, and the preclusion of direct promoting effects of catecholamines and prostaglandins on malignant tissue growth. To assess the safety of such pharmacological treatments in the context of oncologic surgery, the current study evaluates wound healing efficacy in the skin, muscle, and colon tissues in rats undergoing colonic anastomosis. Methods: F344 rats were treated daily with a COX-2 inhibitor (etodolac), a b-adrenergic blocker (propranolol), both drugs or vehicles. All rats underwent skin punch biopsy, and half were also subjected to laparotomy and colonic anastomosis. Tensile strength of the abdominal wall and colonic bursting pressure were assessed on Days 3, 7, and 30 postoperatively, and skin biopsy site healing was scored on Days 2, 4, and 6 postoperatively. Results: None of the drug treatments produced any deleterious effects along the expected course of tissue healing. On Day 30, colon bursting pressure showed an abnormal strengthening in animals undergoing anastomosis compared to non-operated animals, across all drug treatments. This abnormal strengthening was attenuated by etodolac. In the skin, surgery reduced healing rate, irrespective of drug treatments. Conclusions: Effective doses of etodolac and propranolol caused no negative effects on wound healing processes in rats. The apparent safety of such treatments, together with their potential clinical benefits, suggests the incorporation of these treatments in oncologic patients undergoing curative tumor resection.
Highlights
Surgery to excise the primary tumor is crucial in the great majority of cancer patients presenting solid tumors
Critical to any surgical procedure is an effective process of tissue healing, which may be affected by perioperative administration of drugs
Etodolac and/or propanol effets on wound healing in colonic anastomosis removed, and each end of the excised section was placed in a tensiometer
Summary
Surgery to excise the primary tumor is crucial in the great majority of cancer patients presenting solid tumors. While this treatment is beneficial in removing the major mass of malignant cells, the surgical stress, and other aspects of tumor removal, have been suggested to promote cancer recurrence [1, 2, 3, 4, 5, 6, 7, 8]. Critical to any surgical procedure is an effective process of tissue healing, which may be affected by perioperative administration of drugs. Failure of intestinal anastomosis, which usually occurs during the first postoperative week [13, 14, 15], is associated with increased morbidity and mortality [16, 17]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Int. Journal of Clinical Pharmacology and Therapeutics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
